Contents 3 min read

Claim and source comparison

Rhodiola: a fatigue review, two human trials and the NIH safety summary.

· Bounded source comparison; not a complete clinical review or independent medical endorsement.

Human randomized controlled trial

Darbinyan et al. (2000) compared SHR-5 extract with placebo in a crossover trial in 56 healthy physicians on night duty. Improvements in fatigue-related tests were reported in the extract group during the first two weeks.

This crossover trial in 56 physicians assessed a specific SHR-5 extract during night duty. Test findings in the first two weeks do not establish long-term effects or the same result with every product.

Source 1 · Abstract read

Systematic review / meta-analysis

Findings across the 11 studies in the Ishaque et al. (2012) review were conflicting. Every study had a high risk of bias or reporting gaps that prevented assessment of bias.

Positive findings on some tests do not resolve these methodological problems. The review does not establish lasting cognitive enhancement or efficacy of all Rhodiola products.

Source 5 · Full text read

Human randomized controlled trial

Punja et al. (2014) reported fatigue measures favoring placebo in a 42-day placebo-controlled Rhodiola trial involving 48 nursing students on shift work. The trial used 364 mg capsules.

This small trial is limited to this product and shift-work setting; it does not establish harm from all Rhodiola products. Total adverse-event counts did not differ between groups.

Source 6 · Full text read

Official safety summary

NIH NCCIH highlights reported interactions between Rhodiola and losartan. Safety during pregnancy and breastfeeding is insufficiently known; people taking medicines should consult a health professional.

The NCCIH observation on use up to 12 weeks is not a guarantee of long-term safety. A reported interaction does not imply the same magnitude of risk with every blood-pressure medicine.

Source 7 · Official summary read

Our evidence and source methodology

rhodiola rosea: conceptual editorial illustration
Conceptual editorial artwork; not a research finding or evidence of clinical benefit in humans.

What is Rhodiola Rosea?

Rhodiola rosea is traditionally used for fatigue and stress. Some small trials report benefits but have methodological problems; NCCIH finds insufficient reliable evidence to determine health benefits.

Active Compounds

Rosavin and salidroside are marker compounds used to standardize Rhodiola extracts. A percentage alone does not establish clinical efficacy or equivalence between different extracts.

Mechanism of Effect

Cellular and animal findings in this section do not establish clinical benefit in humans.

Clinical Evidence

Darbinyan et al. (2000) compared SHR-5 extract with placebo in a crossover trial in 56 healthy physicians on night duty. Improvements in fatigue-related tests were reported in the extract group during the first two weeks.

This crossover trial in 56 physicians assessed a specific SHR-5 extract during night duty. Test findings in the first two weeks do not establish long-term effects or the same result with every product.

Findings across the 11 studies in the Ishaque et al. (2012) review were conflicting. Every study had a high risk of bias or reporting gaps that prevented assessment of bias.

Positive findings on some tests do not resolve these methodological problems. The review does not establish lasting cognitive enhancement or efficacy of all Rhodiola products.

Punja et al. (2014) reported fatigue measures favoring placebo in a 42-day placebo-controlled Rhodiola trial involving 48 nursing students on shift work. The trial used 364 mg capsules.

This small trial is limited to this product and shift-work setting; it does not establish harm from all Rhodiola products. Total adverse-event counts did not differ between groups.

Dose information and research limits

Dose information and research limits

This dose information describes research or product context; it is not a personal prescription, established safe upper limit or efficacy guarantee for healthy people. Extracts and different formulations should not be treated as equivalent milligram for milligram.

Controlled human trials have not established that specific on/off cycles prevent tolerance. Drug or supplement frequency should not be set by a personal online protocol.

Safety and Side Effects

NCCIH describes rhodiola as possibly safe for up to 12 weeks; this does not establish long-term safety or safety of every product. Dizziness, headache and insomnia may occur. Traditional-use history does not resolve this uncertainty. People taking medicines, pregnant or breastfeeding should consult a health professional.

NIH NCCIH highlights reported interactions between Rhodiola and losartan. Safety during pregnancy and breastfeeding is insufficiently known; people taking medicines should consult a health professional.

The NCCIH observation on use up to 12 weeks is not a guarantee of long-term safety. A reported interaction does not imply the same magnitude of risk with every blood-pressure medicine.

Related research and reading

These links show explicit editorial topic connections; they do not confirm a mechanism, efficacy or the safety of combined use. News dates refer to the source or event.

Educational guides

Sources

  1. Darbinyan V, et al. (2000). Rhodiola rosea in stress induced fatigue - a double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night duty. Phytomedicine, 7(5), 365–371. PubMed · PMID 11081987
  2. Spasov AA, et al. (2000). A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regimen. Phytomedicine, 7(2), 85–89. PubMed · PMID 10839209
  3. Shevtsov VA, et al. (2003). A randomized trial of two different doses of a SHR-5 Rhodiola rosea extract versus placebo and control of capacity for mental work. Phytomedicine, 10(2-3), 95–105. PubMed · PMID 12725561
  4. Panossian A, Wikman G. (2010). Effects of Adaptogens on the Central Nervous System and the Molecular Mechanisms Associated with Their Stress-Protective Activity. Pharmaceuticals, 3(1), 188–224. PubMed · PMID 27713248
  5. Ishaque S, et al. (2012). Rhodiola rosea for physical and mental fatigue: a systematic review. BMC Complementary and Alternative Medicine, 12, 70. PubMed · PMID 22643043
  6. Punja S, Shamseer L, Olson K, Vohra S. (2014). Rhodiola Rosea for Mental and Physical Fatigue in Nursing Students: A Randomized Controlled Trial. PLoS ONE, 9(9), e108416. PubMed · PMID 25268730
  7. National Center for Complementary and Integrative Health. Rhodiola: Usefulness and Safety. https://www.nccih.nih.gov/health/rhodiola NIH NCCIH

Link verification checks the identity of the publication; it does not constitute independent expert review of clinical claims. Our evidence and source methodology · Source directory

Frequently Asked Questions